MVision AI provides AI-powered solutions for radiotherapy, including products like Contour+, Guide, and Verify, which enhance precision in radiation oncology by automating and improving the contouring process.
MVision AI presents the GBS™ solution, a comprehensive suite for radiotherapy that aids healthcare professionals in delivering efficient and precise treatment. GBS™ comprises three main components: Contour+, Verify, and Guide, designed to transform radiotherapy processes through AI-powered tools.
Key Components of GBS™:
Contour+: This AI-powered auto-contouring software quickly delineates organs-at-risk (OARs) and lymph node areas, adhering to industry guidelines. It significantly reduces manual work by up to 95%, yielding consistent, high-quality contours that facilitate inter-clinic collaboration.
Verify: A contour comparison tool that allows clinicians to juxtapose user-generated and AI-generated contours. It supports a rigorous assessment of contour accuracy, thereby fostering trust in AI-based segmentation by providing benchmarks such as Dice score and Hausdorff distance.
Guide: An interactive training platform that enhances contouring expertise and guideline adherence among practitioners. Guide offers access to a library of peer-reviewed, expert-verified reference contours, enabling clinicians to assess AI-generated contours effectively.
Benefits of GBS™:
Increased Efficiency: By automating the contouring process and reducing variability, clinicians can focus more on patient interaction, ultimately decreasing waiting times and enhancing treatment accessibility.
Standardization and Consistency: GBS™ supports standardization through unified guideline-based contours, thereby allowing more reliable and consistent treatment planning across clinics.
Cost-Effectiveness: With a significant reduction in contouring time, GBS™ delivers substantial cost savings.
Security and Compliance: Contour+ meets GDPR and HIPAA standards, ensuring patient data protection with encrypted and pseudo-anonymized data processing.
MVision AI and Impact on Cancer Care:
MVision AI, established in 2017, leverages AI technology to support cancer care innovation. By focusing on enhancing radiotherapy workflow efficiency, the organization aims to improve patient outcomes through accelerated treatment planning. The team behind MVision AI comprises radiation oncologists, dosimetrists, medical physicists, and engineers, all committed to supporting global radiotherapy practices.
Testimonials:
Healthcare professionals have highlighted the efficiency gains and quality improvements offered by MVision’s solutions. For instance, Dr. Giuseppe Sasso from Te Toka Tumai Hospital in Auckland noted significant workflow enhancements, while Timo Kiljunen from Docrates Cancer Center in Helsinki emphasized the benefits of same-day scheduling enabled by MVision AI’s automation.
MVision AI Products and Services:
The company offers its products globally, supported by numerous distributors. Alongside product offerings, MVision AI provides resources through a knowledge center that contains articles, webinars, and publications to educate and inform on best practices and developments in radiation oncology.
Overall, MVision AI’s solutions are instrumental in refining radiotherapy treatment planning by promoting standardization, efficiency, and precision in cancer care.